F W Verheugt
Overview
Explore the profile of F W Verheugt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
1222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verheugt F
Ned Tijdschr Geneeskd
. 2004 Apr;
148(14):645-7.
PMID: 15106312
Over the past 10 years it has become clear that passive smoking is correlated with an increased risk of coronary heart disease. The relative risk of 25-30% is comparable to...
2.
Verheugt F, Lamfers E, Aengevaeren W
Ned Tijdschr Geneeskd
. 2003 Nov;
147(41):2001-4.
PMID: 14587140
Although fibrinolytic therapy for acute myocardial infarction is widely used and can be administered prior to hospitalisation, it is only successful in restoring full early coronary patency in about 60%...
3.
Keuper W, Brouwer M, Luijten J, Uijen G, van der Werf T, Verheugt F
Ned Tijdschr Geneeskd
. 2003 Jul;
147(25):1222-8.
PMID: 12848058
Objective: To evaluate the completion of the Utstein-style forms after cardiopulmonary resuscitation (CPR) in the St Radboud University Medical Center, Nijmegen (UMCN), the Netherlands, and to assess the outcomes of...
4.
Van de Werf F, Barron H, Armstrong P, Granger C, BERIOLI S, Barbash G, et al.
Eur Heart J
. 2001 Dec;
22(24):2253-61.
PMID: 11728145
Background: Fibrinolytic therapy increases the risk of bleeding events. TNK-tPA (tenecteplase) is a variant of rt-PA with greater fibrin specificity and reduced plasma clearance that can be given as a...
5.
Verheugt F
Cardiol Rev
. 2001 Nov;
9(6):325-8.
PMID: 11696261
Oral anticoagulation is one of the oldest ways for preventing secondary ischemic heart disease. With the introduction of aspirin, and low-dose aspirin in particular, the interest in oral anticoagulants has...
6.
7.
Ten Berg J, Kelder J, Suttorp M, Verheugt F, Thijs Plokker H
J Am Coll Cardiol
. 2001 Oct;
38(4):1061-9.
PMID: 11583883
Objectives: The goal of this research was to study the effect of planned angiography on late clinical outcome after percutaneous coronary intervention. Background: It is still largely unknown whether planned...
8.
Verheugt F
Ned Tijdschr Geneeskd
. 2001 Sep;
145(36):1751-2.
PMID: 11572178
Referring to the INSIGHT trial published in The Lancet, Bayer Netherlands states in an advertisement in Dutch medical journals that nifedipine reduces cardiovascular events by 50% in patients with hypertension...
9.
10.
Verheugt F
Thromb Res
. 2001 Sep;
103 Suppl 1:S113-6.
PMID: 11567678
Glycoprotein IIB/IIIA receptor blockers given early to patients with ST segment elevation acute coronary syndrome improves early coronary patency, both in the absence and presence of thrombolytic therapy. Glycoprotein IIB/IIIA...